The goal is to target the clinically significant tumor while monitoring the residual prostate tissue. This allows significantly better preservation of erectile function and continence. There are no long-term data yet for focal treatment. Accordingly, this therapy is being monitored very closely at our institution and is being investigated as part of a prospective study.
As a patient, you cannot register directly for a consultation. Please have your primary care physician, specialist refer you. If you have any questions, please use our contact form.